Albumin for Hepatocellular Carcinoma

Clinical trial NCT03974074 · UNKNOWN

Trial details

NCT number: NCT03974074
Sponsor: Guangxi Medical University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Hypoproteinemia

Start date: 2019-03-01
Primary completion: 2020-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.